CANFAR Research Grants - Recipients

Since 1987, CANFAR has granted Canadian research projects totaling more than $18 million. Our Canadian researchers have been responsible for some of the most significant breakthroughs in the HIV and AIDS field.

 

We are proud to announce the recipients for the 2011-2012 year:


Research Grants ($80,000): First Year of Two Year Grants 2011/2012

Researcher: Dr. Clemon George
Co-Investigators: Dr. Stanley Read, Dr. Delon Brennen
Institution: University of Ontario Institute of Technology
Project: Getting to Zero: Male Circumcision of HIV Prevention research project in the Bahamas

Researcher: Dr. Mary Lou Smith
Co-Investigators: Dr. Stanley Read, Dr. Ari Bitnun
Institution: Hospital for Sick Children and University of Toronto
Project: Neurodevelopmental outcomes of pre-and perinatal exposure to antiretroviral treatment in HIV-uninfected children

Researcher: Dr. Reina Bendayan
Institution: The Leslie Dan Faculty of Pharmacy
Project: Role of Drug Transporters in Antiretroviral Drug Absorption and Grus-Drug Interactions in Intestinal Tissue


Researcher: Dr. Clifford Lingwood
Co-Investigator: Dr. Donald Branch
Institution: Hospital for Sick Children
Project: Glycolipid mimetics block gp120 chemokine receptor binding and HIV infection

Researcher: Dr. Mark Wainberg
Co-Investigator: Dr. Thibault Mesplede
Institution: McGill University AIDS Centre
Project: Investigating the role of subtype-specific polymorphisms in HIV-1 resistance to integrase inhibitors


Researcher: Dr. Lena Serghides
Co-Investigators: Dr. John Sled, Dr. Eszter Papp
Institution: University Health Network
Project: The impact of HIV protease inhabitors on angiogenesis during pregnancy

 

Research Grants ($80,000): Year 2 of 2010/2011 Projects

Researcher: Dr. Michel Alary
Co-Investigators: Dr. Marie-Claude Boily, Dr. Stephen Moses, Dr. Marissa Becker, Dr. Peter Vickerman, Dr. Reynold Washington, Dr. BM Ramesh, Dr. Sharmistha Mishra
Institution: Centre Hospitalier affilié Universitaire de Quebec and Université Laval
Project: Antiretroviral-based combination prevention in India: predicting population-level effectiveness and emergence of drug resistance

Researcher: Dr. Xiaojian Yao
Institution: University of Manitoba
Project: Investigation of functional role of HIV-1 integrase in viral nuclear import and integration

Researcher: Dr. Charu Kauschic
Institution: McMaster University
Project: Role of genital tract epithelial cells in HIV infection of the female genital tract


Researcher: Dr. Alan Cochrane
Institution: University of Toronto
Project: Probing host factors essential for HIV-1 Gene Expression

 

Research Grants ($25,000): One Year Grants 2011/2012

Researcher: Dr. Jaqueline Sas
Institution: Canadian HIV Trials Network
Project: CANFAR/CTN Post-Doctoral Fellowship

Researcher: Dr. Angela Crawley
Institution: Ottawa Hospital Research Institute
Project: The expression and role of solubles IL-7 receptor alpha in HIV-HCV co-infection

Researcher: Dr. Sadhna Joshi
Co-Investigator: Dr. Stanley Read
Institution: University of Toronto
Project: A microflora defense against HIV infection

Researchers: Dr. Darrell Tan
Co-Investigators: Dr. Sharon Walmsley, Dr. Janet Raboud, Dr. Angela Cheug, Dr. Jason Brophy, Dr. Lindy Samson
Institution: St. Michael’s Hospital
Project: A case control study of novel bone imaging techniques and bone turnover markers in HIV-infected persons with or without fragility fractures

Researcher: Dr. Jonathan Angel
Co-Investigator: Dr. John Bell
Institution: University of Ottawa/Ottawa Hospital
Project: Oncolytic viruses as a potential approach to eliminate the HIV reservoir


Researcher: Dr. Mani Larijani
Institution: Memorial University of Newfoundland
Project: Evaluating the role of APOBEC3G in anti-HIV adaptive immunity: implications for the development of APOBEC-based therapies


Researcher: Dr. Istvan Mucsi
Co-Investigators: Dr. Marina Klein, Dr. Ahsan Alam
Institution: The Research Institute of the McGill University Health Centre
Project: Kidney function, antiretroviral therapy and iron deficiency as potential determinants of plasma Fibroblast Growth Factor-23 levels in patients with HIV and Hepatitis C virus Co-infection